Hutchison China MediTech to partner with Nestle subsidiary in healthcare JV
Nestlé Health Science SA, a fully-owned subsidiary of Nestlé SA, and Hutchison China MediTech have announced that all regulatory approvals required for the establishment of a 50/50 joint venture Nutrition Science Partners Limited have been received.
Nestl Health Science SA, a fully-owned subsidiary of Nestl SA, and Hutchison China MediTech have announced that all regulatory approvals required for the establishment of a 50/50 joint venture Nutrition Science Partners Limited have been received.
Hutchison China MediTech said that the purpose of the joint venture would be to research, develop, manufacture and market novel medicines and nutritional products derived from botanical plant origins.
The company added that Nutrition Science Partners would focus on gastrointestinal indications and could in the future expand into the metabolic disease and brain health areas.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
 
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Hutchison China MediTech's share price was up 3.85% to 526.50p at 11:13 on Friday.
MF
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
- 
 Family investment companies explained: how the ultra wealthy shield their money from the taxman Family investment companies explained: how the ultra wealthy shield their money from the taxmanWealthy families are increasingly turning to family investment companies to keep more of their money away from HMRC – but what are these arrangements and how do they work? 
- 
 How to boost your pension pot as 35% of UK over 50s face huge retirement savings gap How to boost your pension pot as 35% of UK over 50s face huge retirement savings gapOver 50s are facing a later life with little to no funds - but there are steps you can take now to boost your pot. 
 
